Dow Down 0.92% Nasdaq Down 0.83%

Clovis Oncology, Inc. (CLVS)

-NasdaqGS
51.44 0.35(0.69%) Oct 22, 4:00PM EDT
Prev Close:51.09
Open:50.74
Bid:45.00 x 100
Ask:N/A
1y Target Est:81.11
Beta:2.44
Next Earnings Date: 6-Nov-14CLVS Earnings announcement
Day's Range:49.43 - 52.13
52wk Range:35.33 - 93.33
Volume:717,556
Avg Vol (3m):771,178
Market Cap:1.75B
P/E (ttm):N/A
EPS (ttm):-3.55
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLVS

Comparison

Symbol% ChgMkt Cap
CLVSUp 0.69%1.75B
IMMU338.93M
LRUSFN/A
THLD176.32M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):127.35
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-4.06
Quarterly EPS Est (Sep-14) :-1.07
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback